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Abstract
Background: Nasopharyngeal carcinoma (NPC), also known as Cantonese cancer, is rare worldwide, but has particularly
high incidence in North Africa and Southeast Asia, especially in Guangdong, China, such as Guangzhou. Tobacco causes
head and neck cancers, but nasopharyngeal carcinoma is not included as causally related to smoking in the 2014 United
States Surgeon General’s report. Prospective evidence remains limited. We used Guangzhou Occupational Cohort data
to conduct the first and robust prospective study on smoking and NPC mortality in an NPC high-risk region.
Methods: Information on demographic characteristics and smoking status was collected through occupational health
examinations in factories and driver examination stations from March 1988 to December 1992. Vital status and causes of
deaths were retrieved until the end of 1999. Cox proportional hazard model was used to assess the association of
smoking with NPC mortality.
Results: Of 101,823 subjects included for the present analysis, 34 NPC deaths occurred during the average 7.3 years of
follow up. The mean age (standard deviation) of the subjects was 41 (5.7) years. Compared with never smokers, the
hazard ratio (HR) of NPC mortality was 2.95 (95 % confidence interval 1.01–8.68; p = 0.048) for daily smokers and 4.03
(1.29–12.58; p = 0.016) for smokers with more than 10 pack-years of cumulative consumption, after adjusting for age,
sex, education, drinking status, occupation and cohort status and accounting for smoking-drinking interaction. The risk
of NPC mortality increased significantly with cigarettes per day (p for trend = 0.01) and number of pack-years (p for
trend = 0.02).
Conclusions: In this first and largest cohort in a high NPC risk region, smoking was associated with higher NPC
mortality. The findings have shown statistically significant dose–response trend between smoking amount and
smoking cumulative consumption and the risk of NPC mortality, but due to the small event number, further studies
with larger sample size are needed to confirm the findings in the present study. Our results support that smoking is
one of the risk factors likely to be causally associated with NPC mortality.
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Background
Nasopharyngeal carcinoma (NPC), also known as Canton-
ese cancer, has a distinctive geographic variation [1–3]. It
is rare worldwide, but the incidence is particularly high in
North Africa and Southeast Asia, especially in Guangdong,
China (for instance, Guangzhou City). The peak age of
NPC is also different in high and low risk populations
(high-risk: 40–55 years, low-risk: 15–24 and 65–79 years),
but the male to female ratio is 2.5–3 to 1 across popula-
tions consistently. Tobacco is classified as a group 1 car-
cinogen by the International Agency for Research on
Cancer (IARC). It is a well-known causal factor for head
and neck cancers, except NPC.
In the past 3 to 4 decades, 43 case–control studies and 6
cohort studies (including our Guangzhou Occupational
Cohort Study) have reported results on the association
between tobacco use and NPC. In 2012, IARC reported a
causal association of smoking with NPC based on 14 case–
control studies and 6 cohort studies [4]. A meta-analysis
[5] included 28 case–control and 4 cohort studies found a
higher risk of NPC in ever-smokers than never smokers
(pooled odds ratio (OR): 1.60, 95 % confidence interval
(CI): 1.38–1.87). However, the 2014 United States (US)
Surgeon General Report [6] and the 2012 China Tobacco
Hazard Report [7] were undecided on whether the associ-
ation between smoking and NPC is causal.
The quality of these case–control and cohort studies
varied. About two-thirds of them were conducted in low
or medium risk areas. Much of the evidence came from
case–control studies, which might be subject to recall
bias with over-estimated odds ratios. Prospective studies
reporting significant associations between smoking and
NPC risk are scarce.
The Guangzhou Occupational Cohort was among the
largest cohorts included in the Asia Pacific Cohort Studies
Collaboration with numerous publications [8–10]. The
Guangzhou Occupational Cohort has the largest number
of NPC deaths in high risk areas, whereas the numbers in
the other cohorts were too small for further analysis. The
aim of the present paper was to examine whether baseline
smoking predicted NPC mortality in Chinese adults in
Guangzhou, which is a high NPC risk region.
Methods
Subjects
The Guangzhou Occupational Diseases Prevention and
Treatment Center established a regular occupational health
examination system to monitor the workers’ health and
occupational hazards [11]. Depending on their severity of
occupational exposure, workers from factories, and drivers
renewing their driver’s license were required to undergo
biannual, annual or biennial medical examinations to cer-
tify their fitness. The examination results were recorded in
standardized data collection forms by physicians [12].
The Guangzhou Occupational Cohort was estab-
lished from the information in the standardized forms.
A total of 165,634 subjects (129,135 men and 36,499
women) were included from 399 factories and 11
driver examination stations from 1988 to 1992. These
factories and stations covered about 67 and 75 % of all
eligible factories and Guangzhou resident drivers, re-
spectively. Hence, the whole cohort comprised of 2 sub-
cohorts: workers (n = 82,160) and drivers (n = 83,474).
Details of the methods were reported elsewhere [11, 12]
and this cohort has contributed several publications on
smoking and related mortality to the Asia Pacific Cohort
Studies Collaboration [8–10].
The vital status and cause of death of all subjects were
ascertained from factories, Public Health Bureau Statistics
Office, funeral homes and local police stations through
December, 1998 in the worker cohort and September, 1999
in the driver cohort by two physicians and double checked
by a medically qualified epidemiologist [12]. During the
follow up period, 95 NPC deaths (76 workers, 19 drivers)
had occurred [12]. All coders were blinded to the subjects’
baseline information, and the International Classification of
Disease 9th revision (ICD-9) was used to classify the causes
of death [11–13].
Ethics approval (for all sites and participants) was ob-
tained from the Ethics Committee, Faculty of Medicine,
The University of Hong Kong. Permission to use data
was granted by Guangzhou Occupational Diseases Pre-
vention and Treatment Centre.
Analytical cohort and exposure
The present analysis excluded subjects who had cancers
(including NPC), cardiovascular diseases, respiratory
diseases and other diseases at baseline; deaths within
two years; and those who had no information on daily
smoking amount or duration. The final analytical co-
hort included 101,823 subjects (86,269 men and 15,554
women) (Additional file 1: Figure S1).
Information on demographic characteristics, smoking
and drinking status, occupational exposures, and medical
history was collected at baseline [11–13]. Data on smok-
ing included smoking status (never smokers, occasional
smokers, daily smokers and ex-smokers), number of ciga-
rettes smoked per day, and smoking duration (years of
smoking). A daily smoker was defined as one who smoked
at least one cigarette per day for at least six months [11].
The numbers of occasional (5 %) and ex-smokers (0.6 %)
were too small for statistical analysis and were excluded
from the analysis.
Cumulative tobacco consumption (pack-years) was
computed as follows: number of pack-years = (number
of cigarettes smoked per day × number of years of
smoking)/20 (20 cigarettes per pack).
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Statistical methods
Cox proportional hazard model was used in SPSS 20.0 to
estimate hazards ratios (HRs) and 95 % confidence inter-
vals (CIs) of NPC mortality for tobacco use adjusting for
age, sex, education level, drinking status, occupation and
cohort status. P for trend was tested by regressing the
smoking variables (e.g., 1 for never smokers, 2 for 1–14
cigarettes/day, and 3 for 15+ cigarettes/day) as continuous
variables in the Cox model.
Alcohol is a well-known risk factor of NPC which can
modify the effect of smoking on NPC risk. [14] Therefore,
interaction between smoking and drinking status was
accounted for the analysis. Smoking and alcohol expo-
sures were also stratified based on the paper by Ferreira
Antunes et al. [15]. The proportional hazards assumption
was checked by visual inspection of plots of log (−log S)
against time, where S is the estimated survival function.
Results
In the final analytical cohort of 101,823 subjects, the total
follow up was 746,159 person-years and the mean follow
up duration was 7.3 years. The subjects were aged 30 to
87 years with a mean (standard deviation) age of 41.0 (5.7)
years. Thirty four NPC deaths were observed (30 male
deaths, 4 female deaths).
Table 1 shows that about 48 % men and almost 54 %
women were aged 35 to 39 years. About 77 % had second-
ary education. Almost all (93 %) were rated as healthy or
fairly healthy by physicians. Daily smoking rate was 53.3 %
in men, but 0.6 % in women. Over 80 % in men and al-
most 98 % women were never drinkers. Missing data were
about 1 % in all variables.
In Table 2, compared with never smokers, the crude HR
of NPC mortality from smoking in daily smokers was 3.57
(95 % CI 1.66–7.65; p = 0.001), the adjusted HR was 2.95
(1.01–8.68; p = 0.048). The crude HR for smoking 15 ciga-
rettes or more per day was 4.52 (2.01–10.14; p < 0.001)
and the adjusted HR was 4.00 (1.29–12.35; p = 0.016).
Smoking for 10 years or more showed a crude HR of
3.94 (1.80–8.60; p = 0.001) and an adjusted HR of 2.93
(0.97–8.89; p = 0.058). The crude and adjusted HR for
smoking more than 10 pack-years was 5.52 (2.50–12.20;
p < 0.001) and 4.03 (1.29–12.58; p = 0.016), respectively.
All the adjusted HRs above were accounted for smoking-
alcohol interaction
Significant trends suggesting increased risk with daily
smoking amount (p for trend = 0.01) and cumulative
consumption (pack-years) (p for trend = 0.01) were ob-
served in the adjusted HRs of Model 1, but the trend
was of borderline significance for smoking duration (p
for trend = 0.06) (Table 2, Model 1). Note that the HRs
in the lower exposure group did not significantly differ-
ent from unity.
The joint effects of smoking and drinking observed for
NPC mortality risk were assessed in Table 3. The use of
the interaction term resulted in an increase in the values
Table 1 Characteristics of the 101,823 subjects in the Guangzhou
Occupational Cohorts, at baseline (1992)
Men Women Total
N = 86,269 (%) N = 15,554 (%) N = 101,823 (%)
Age, years
30–34 4568 (5.5) 993 (6.4) 5561 (5.5)
35–39 41,645 (48.3) 8452 (54.3) 50,097 (49.2)
40–44 21,769 (25.2) 4107 (26.4) 25,876 (25.4)
45–49 9663 (25.2) 1488 (9.6) 11,151 (11.0)
50–54 5033 (5.8) 392 (2.5) 5425 (5.3)
55–59 3077 (3.6) 80 (0.5) 3157 (3.1)
60+ 514 (0.6) 42 (0.3) 556 (0.6)
Marital status
Married 85,247 (98.8) 15,143 (97.4) 100,390 (98.6)
Not married 510 (0.6) 345 (2.2) 855 (0.8)
Missing 512 (0.6) 66 (0.4) 578 (0.6)
Education level
Primary or below 7440 (8.6) 3152 (20.3) 10,592 (10.4)
Secondary 67,405 (78.1) 11,073 (71.2) 78,478 (77.1)
Tertiary 10,894 (12.6) 1222 (7.9) 12,116 (11.9)
Missing 530 (0.6) 107 (0.7) 637 (0.6)
Rank
Cadre 19,535 (22.6) 3326 (21.4) 22,861 (22.5)
Worker 65,458 (75.9) 12,090 (77.7) 77,548 (76.2)
Missing 1276 (1.5) 138 (0.9) 1402 (1.4)
Health status
Healthy 71,337 (82.7) 11,666 (75.0) 83,003 (81.5)
Fairly Healthy 9018 (10.5) 2642 (17.0) 11,660 (11.5)
Abnormal 1332 (1.5) 74 (0.5) 1406 (1.4)
Unknown 4346 (5.0) 1061 (6.8) 5407 (5.3)
Missing 236 (0.3) 111 (0.7) 347 (0.3)
Smoking status
Never smokers 40,119 (46.5) 15,464 (99.4) 55,583 (54.6)
Occasional smokers 114 (0.1) 1 (0.01) 115 (0.1)
Daily smokers 45,988 (53.3) 89 (0.6) 46,077 (45.3)
Ex-smokers 13 (0.02) 0 13 (0.01)
Missing 35 (0.04) 0 35 (0.03)
Drinking status
Never drinkers 71,340 (82.7) 15,164 (97.5) 86,504 (85.0)
Occasional smokers 6273 (7.3) 341 (2.2) 6614 (6.5)
Daily drinkers 8432 (9.8) 43 (0.3) 8475 (8.3)
Ex-drinkers 27 (0.03) 0 27 (0.03)
Missing 197 (0.2) 6 (0.04) 203 (0.2)
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of the HRs of almost all the smoking-related variables.
However, the number of NPC deaths was small (n = 27)
and the 95 % CI were wide.
The differences between the HRs in the two sub-cohorts
were tested by including the interaction term of cohort
status by smoking. The p value for the interaction term
was 0.44, indicating that the association of smoking and
NPC mortality did not vary by sub-cohort status.
Discussion
We showed that higher daily smoking amount and greater
cumulative consumption being associated with higher risk
of NPC mortality. An earlier paper from the Guangzhou
Occupational Study showed some preliminary results of
the association in 2004 [13]. However, this previous ana-
lysis only focused on the worker sub-cohort (n = 82,160),
compared the risk between ever and never smokers and
did not report dose–response results. The present study
included the driver sub-cohort. We carefully used the
most appropriate exclusion criteria for analysis and pro-
vided more robust and the first prospective evidence with
dose–response relation from the largest cohort in an NPC
endemic area.
According to the World Health Organization (WHO)
[16], the 3 histological types of NPC have different distri-
bution in high and low risk areas. Over 90 % of NPC cases
in high-risk areas are undifferentiated carcinoma (Type
III), while squamous-cell carcinoma (Type I) is the major
histologic type in low-risk areas [5, 17]. Previous studies,
including a meta-analysis [5], demonstrated that the
association between smoking and NPC was stronger in
squamous-cell carcinoma (Type I, main cell type in low-
risk population) than that in undifferentiated carcinoma
(Type III, main cell type in high-risk population) [5, 18]. A
slightly higher risk of squamous-cell NPC (pooled OR
2.20, 95 % CI 1.63–2.98) than that of undifferentiated
NPC (pooled OR 1.27, 95 % CI 0.98–1.66) was found in
Xue’s meta-analysis from 4 case–control studies, which
might be subject to recall bias resulting in higher ORs.
Studies included in the meta-analysis also had the hetero-
geneity problem (p < 0.01, I2 = 86). Unfortunately, we did
not have histology data for the NPC deaths. But other
studies in Guangzhou and other high-risk areas have
shown that the predominant type of NPC is undifferenti-
ated carcinoma (which accounts for 90 % of cases in en-
demic regions) [3, 19, 20]. Our results may indicate that
smoking has a stronger (than previously expected) associ-
ation with NPC mortality in high-risk areas as well as
those in low-risk areas.
Among all 6 cohort studies [13, 17, 18, 21–23] on smok-
ing and NPC, Guangzhou had the highest age standard-
ized incidence rate (ASIR) of NPC in men (22.2/100,000)
and in women (9.9/100,000) [24], which was twice as high
as those in intermediate NPC risk regions of Singapore
(10.5/100,000 in men, 5.4/100,000 in women) [17] and
Taiwan (9.02/100,000 in men, 2.79 in women) [25] and
more than 20 times higher than those in low risk regions
of the US and United Kingdom (1/100,000).
As mentioned above, only six cohort studies including
the present Guangzhou cohort [13] had reported results
Table 2 Hazard ratios (HRs) of NPC deaths by smoking status in the combined cohort (both sexes)
Total person-years of participants Mortality rate of NPC per 10,000
person-years (95 % CI)
Crude HR (95 % CI) Model 1 HR (95 % CI)
Never smokers 409,095 0.22 (0.11–0.42) 1.00 1.00
Smoking status
Daily smokers 337,064 0.74 (0.50–1.10) 3.57 (1.66–7.65)** 2.95 (1.01–8.68)*
Smoking amount (cigarettes/day)
1–14 162,244 0.49 (0.25–0.99) 2.45 (0.94–6.37) 1.74 (0.45–6.79)
15+ 174,820 0.97 (0.60–1.56) 4.52 (2.01–10.14)** 4.00 (1.29–12.35)*
P for trend <0.001 0.012
Smoking duration (years)
1–9 87,556 0.46 (0.17–1.22) 2.36 (0.72–7.73) 3.07 (0.69–13.62)
10+ 249,508 0.84 (0.55–1.29) 3.94 (1.80–8.60)** 2.93 (0.97–8.89)
P for trend 0.001 0.064
Smoking cumulative consumption (pack-years)
< 10 181,243 0.33 (0.15–0.74) 1.65 (0.59–4.66) 1.76 (0.45–6.89)
10+ 155,821 1.22 (0.78–1.91) 5.52 (2.50–12.20)** 4.03 (1.29–12.58)*
P for trend <0.001 0.014
Model 1- adjusted by age, sex, education, drinking status, cohort status & occupation (including cadre level workers, general workers, and drivers), accounted for
smoking-drinking interaction
*p < 0.05, **p < 0.01
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on NPC and tobacco use [17, 18, 21–23]. Among the
two cohort studies conducted in low-risk areas, only the
one from the US [18] reported a significant trend with
daily smoking amount, but this study did not find a sig-
nificant trend for smoking duration and did not report
results on cumulative consumption. The other study
from the British doctors cohort [23] did not report any
significant results because of the small number of NPC
(n = 4). In endemic areas, two cohort studies in Taiwan
[21, 22] and one cohort study in Singapore [17] reported
a significant increase in NPC risk in heavy and chronic
smokers, but only the Singapore study showed a dose–
response relation by smoking duration, whereas the two
Taiwan studies did not show any significant trends.
Our results have provided new prospective evidence that
heavy and chronic smokers had significantly increased risk
of NPC mortality, which are consistent with most case–
control studies and the 4 cohort studies from Taiwan,
Singapore and the US [5, 17, 18, 22]. The adjusted HR
from our study was 3.26 (1.14–9.36) in heavy smokers
who smoked more than 15 cigarettes per day, which was
consistent (with overlapping 95 % CI) with that of 3.3
(0.8–14.0) from Liaw et al. in Taiwan. We observed signifi-
cant trends suggesting a dose–response relation for daily
smoking amount, which was consistent with the findings
from the US cohort study. [18] Moreover, our study was
the first to observe a significant trend suggesting dose–re-
sponse relation for cumulative tobacco use among all co-
hort studies above. But the limited number of NPC deaths
restricted our grouping of exposure levels (only three
exposure levels). The significant trends might be due to
the large HRs in the group with the greatest exposure.
Table 3 Individual and joint effects of smoking and drinking on NPC adjusted for age, sex, education, cohort & occupational status
Category Total person-years
of participants
Mortality rate of NPC per 10,000
person-years (95 % CI)
No of
deaths
Model 2 HR
(95 % CI)
Smoking and drinking status
Never smoker and never drinker 390,148 0.21 (0.10–0.41) 8 1.00
Never smoker and daily drinker 6265 1.60 (0.22–11.33) 1 4.19 (0.47–37.22)
Daily smoker and never drinker 240,998 0.50 (0.28–0.88) 12 2.95 (1.01–8.68)*
Daily smoker and daily drinker 56,597 1.06 (0.48–2.36) 6 3.38 (0.95–11.97)
Smoking amount and drinking status (cigarettes/day)a
Never smoker and never drinker 390,148 0.21 (0.10–0.41) 8 1.00
Never smoker and daily drinker 6265 1.60 (0.22–11.33) 1 4.49 (0.51–39.90)
Level 1 smoking amount and never drinker 125,001 0.32 (0.12–0.85) 4 2.15 (0.56–8.18)
Level 1 smoking amount and daily drinker 21,113 / 0 /
Level 2 smoking amount and never drinker 115,997 0.53 (0.28–1.02) 8 3.55 (1.12–11.31)*
Level 2 smoking amount and daily drinker 35,485 1.28 (0.58–2.86) 6 4.86 (1.34–17.61)*
Smoking duration and drinking status (years)b
Never smoker and never drinker 390,148 0.21 (0.10–0.41) 8 1.00
Never smoker and daily drinker 6265 1.60 (0.22–11.33) 1 4.21 (0.47–37.41)
Level 1 smoking duration and never drinker 71,958 0.42 (0.13–1.29) 3 3.52 (0.81–15.34)
Level 1 smoking duration and daily drinker 9877 / 0 /
Level 2 smoking duration and never drinker 169,040 0.53 (0.28–1.02) 9 2.67 (0.87–8.23)
Level 2 smoking duration and daily drinker 46,720 1.28 (0.58–2.86) 6 3.61 (1.01–12.93)*
Smoking cumulative consumption and drinking status (pack-years)c
Never smoker and never drinker 390,148 0.21 (0.10–0.41) 8 1.00
Never smoker and daily drinker 6265 1.60 (0.22–11.33) 1 4.65 (0.52–41.41)
Level 1 smoking cumulative consumption and never drinker 143,711 0.28 (0.10–0.74) 4 2.10 (0.55–8.11)
Level 1 smoking cumulative consumption and daily drinker 22,306 / 0 /
Level 2 smoking cumulative consumption and never drinker 97,286 0.82 (0.41–1.64) 8 3.69 (1.15–11.82)*
Level 2 smoking cumulative consumption and daily drinker 34,291 1.75 (0.79–3.89) 6 4.77 (1.30–17.50)*
Model 2 – adjusted for age, sex, education, cohort & occupational status with smoking and alcohol interaction terms
*p < 0.05
aLevel 1: smoked 1–14 cigarettes per day, Level 2: smoked more than 15 cigarettes per day
bLevel 1: 1–9 years of smoking duration, Level 2: more than 10 years of smoking duration
cLevel 1: less than 10 pack-years of smoking cumulative consumption, Level 2: more than 10 pack-years of smoking cumulative consumption
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Because the HRs in the low exposure group did not signifi-
cantly different from unity, a threshold level below which
smoking is not associated with increased risk is possible
and cannot be ruled out from our study. Future studies
with larger sample size are needed to confirm our findings.
Compared with other cohort studies, our study used
lower smoking level to define heavy and chronic smokers
(more than 10 pack-years, more than 10 years smoking or
15 cigarettes per day), but our results still showed a stron-
ger and significant association between smoking and NPC
mortality. Despite the different definitions of heavy expos-
ure, our results are consistent with those of the meta-
analysis by Xue et al. [5].
We recognize the limitations of the small number of
NPC deaths (especially in women) and the wide 95 % con-
fidence intervals of the risk estimates, the lack of data on
nonfatal new cases and the short follow-up. However,
there was only one cohort study [18] which had more
NPC deaths (n = 48) than ours. We are now planning for
a further follow-up of the cohort.
Because alcohol consumption and smoking are import-
ant NPC risk factors [14], alcohol status and smoking-
drinking interaction were accounted for in the present
analysis. The p value for the smoking-drinking interaction
was 0.26, which was not significant. The use of smoking
and alcohol interaction term resulted in an increased in
HRs for combined exposure of alcohol intake and smok-
ing HRs, which suggested an interaction between smoking
and drinking, but the 95 % CIs were very wide. Due to the
small event number, we cannot fully investigate the joint
effects of smoking and drinking and the risk of NPC. Fur-
ther investigations with more NPC deaths are needed.
Although we suspect some drivers did not disclose their
drinking habit or under-reported their consumption dur-
ing the driver license renewal, the results were similar
after including alcohol data.
Sensitivity analysis without female subjects and alcohol
adjustment were performed in Additional file 1: Table S1.
The results of the sensitivity analyses were similar to the
main results above.
In the present analysis, we excluded subjects with NPC
or other diseases at baseline to reduce bias from reverse
causation (people with NPC or diseases would be more
likely to quit smoking). These strict exclusion criteria
probably allowed the better detection of the association
with smoking in the analysis.
Despite its declining incidence and mortality in the
past decades [2], NPC is still among the top 10 common
cancers in epidemic areas, such as Guangzhou [26] and
Hong Kong [27]. The present study should provide con-
vincing new evidence to support causal inference on the
association of smoking with NPC mortality.
China is still in the second stage of tobacco epidemic
[28], and tobacco control is a major public health concern.
Guangdong not only has the most high-risk population of
NPC, but also has a large number of smokers in China
(about 16 million, based on the estimated smoking preva-
lence by Su et al.) [29]. Due to the time gap between smok-
ing and disease occurrence, the consequences of tobacco
use in smokers will continue to expand, including NPC if
the association is causal. Tobacco control in high NPC risk
areas, including smoking cessation, should have additional
benefits in reducing NPC.
Further follow-up of the present cohort, including fatal
and nonfatal NPC is warranted. There are many cohort
studies in China mainland in the Asia Pacific Cohort
Studies Collaboration and elsewhere which can be used
for further follow-up and analysis. Detailed analyses, in-
cluding meta-analyses based on pooled individual data
are low cost studies to examine smoking and other risk
factors of NPC. Information on the histological types of
NPC, which is often lacking in most cancer registries
and NPC epidemiological studies, is essential to estimate
the histology-specific risk of NPC for smoking, and its
interaction with other risk factors (such as EB virus) and
to study the mechanisms of carcinogenesis.
Conclusions
In our study, heavier and chronic smokers had significantly
higher risk of NPC mortality. Significant trends suggesting
dose–response relationships of smoking amount and smok-
ing cumulative consumption and the risk of NPC mortality
were observed in our study, but more prospective cohorts
with more NPC deaths are required to confirm our results,
or to examine whether there is a threshold level of expos-
ure, which has important implications for cancer preven-
tion. The results from this first and largest prospective
study in a high NPC risk region support that smoking is
one of the risk factors likely to be causally associated with
NPC mortality. Strong tobacco control measures are
needed to motivate smokers to stop smoking.
Additional file
Additional file 1: Table S1. Hazard ratios (HRs) of NPC deaths by smoking
status in the combined cohort (men). Figure S1: The flow chart of the
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